Trending...
- Proper Sky Named to the 2026 MSP 501
- 100+ Episodes In, Liftoff with Keith Newman Tells Founders to Stop Publishing More
- Dentists launch independent platform to help practices choose the right technology
BELLEFONTE, Pa. - PennZone -- Actuated Medical, Inc. is pleased to announce that Roger B. Bagwell, Ph.D. is now the Actuated Medical Director, Neural Device Operations. This transition reflects the company's continued expansion in the neural device sector and Dr. Bagwell's pivotal role in advancing Actuated's cutting-edge technologies.
As Director, Neural Device Operations, Dr. Bagwell will oversee the development, optimization, and strategic direction of Actuated's neural-focused device portfolio, Actuated Neuroscience, ensuring performance excellence from concept to commercialization. He will lead engagement with brain researchers and brain computer interface (BCI) companies that are focused on improving outcomes for patients dealing with neurological conditions.
"Our team has made significant strides in helping the neural device researcher achieve better data to improve their understanding of the brain. With Roger at the helm of our neural device operations, we are confident that we will continue delivering groundbreaking solutions to enable clinical researchers to improve patient outcomes." said Maureen L. Mulvihill, Ph.D., President and CEO of Actuated Medical.
More on The PennZone
"I am excited to take this step and transition my position to Director, Neural Device Operations. Actuated Neuroscience has an immense amount of neural technology ideas, and I look forward to leading our talented team in developing advanced solutions that enhance patient care and expand the possibilities of neural device applications." said Roger B. Bagwell, Ph.D.
Actuated Medical is committed to pushing the boundaries of medical technology through innovation and collaboration. This transition underscores the company's dedication to developing advanced solutions that extend the longevity and performance of penetrating neural implants and other neuro-focused medical devices.
About Actuated Medical, Inc.
Actuated Medical is a medical technology innovator that is pioneering motion-based solutions to address critical, unmet clinical needs in gastroenterology and neurology. With an unwavering focus on innovation, safety, and superior quality, the Actuated team is committed to delivering transformative products that empower healthcare professionals to achieve greater precision, enhance efficiency, and drive better patient outcomes while reducing healthcare costs. The company's technologies are backed by a strategic path to commercialization with multiple exit opportunities, supported by invaluable feedback from industry leaders. Actuated holds 43 issued U.S. and international patents, 8 FDA 510(k) clearances, 5 Investigational Device Exemptions (IDEs), 33 pre-submissions, and has completed or is conducting 8 clinical studies. Honored with two Small Business Administration (SBA) Tibbetts Awards for SBIR commercialization excellence (2014 & 2020), Actuated operates out of a state-of-the-art 20,000 sq. ft. facility in central Pennsylvania, certified ISO 13485 and a Woman-Owned Small Business (WOSB), reflecting its steadfast commitment to quality and innovation. actuatedmedical.com
More on The PennZone
###
For media inquiries, please contact Maureen L. Mulvihill, Ph.D. by phone at 814-355-0003 or email at info@actuatedmedical.com.
Additional information can be found by visiting:
ActuatedMedical.com
GripTract.com
ActuatedNeuroscience.com
TubeClear.com
As Director, Neural Device Operations, Dr. Bagwell will oversee the development, optimization, and strategic direction of Actuated's neural-focused device portfolio, Actuated Neuroscience, ensuring performance excellence from concept to commercialization. He will lead engagement with brain researchers and brain computer interface (BCI) companies that are focused on improving outcomes for patients dealing with neurological conditions.
"Our team has made significant strides in helping the neural device researcher achieve better data to improve their understanding of the brain. With Roger at the helm of our neural device operations, we are confident that we will continue delivering groundbreaking solutions to enable clinical researchers to improve patient outcomes." said Maureen L. Mulvihill, Ph.D., President and CEO of Actuated Medical.
More on The PennZone
- DEPIN Studios Sees Surge in Demand After AI Gaming Launch
- Discard Junk Removal Named #1 Junk Removal Company in Sacramento Out of 189 Businesses Evaluated
- J&J Exterminating Mourns the Passing of Founder Bobby John Sr
- Delirious Comedy Club Transforms Into Las Vegas' Newest Live Comedy Studio With Weekly Delirious TV Tapings
- BitTitan Advances MigrationWiz with New Capabilities, Platform Enhancements, and Product Leadership Update
"I am excited to take this step and transition my position to Director, Neural Device Operations. Actuated Neuroscience has an immense amount of neural technology ideas, and I look forward to leading our talented team in developing advanced solutions that enhance patient care and expand the possibilities of neural device applications." said Roger B. Bagwell, Ph.D.
Actuated Medical is committed to pushing the boundaries of medical technology through innovation and collaboration. This transition underscores the company's dedication to developing advanced solutions that extend the longevity and performance of penetrating neural implants and other neuro-focused medical devices.
About Actuated Medical, Inc.
Actuated Medical is a medical technology innovator that is pioneering motion-based solutions to address critical, unmet clinical needs in gastroenterology and neurology. With an unwavering focus on innovation, safety, and superior quality, the Actuated team is committed to delivering transformative products that empower healthcare professionals to achieve greater precision, enhance efficiency, and drive better patient outcomes while reducing healthcare costs. The company's technologies are backed by a strategic path to commercialization with multiple exit opportunities, supported by invaluable feedback from industry leaders. Actuated holds 43 issued U.S. and international patents, 8 FDA 510(k) clearances, 5 Investigational Device Exemptions (IDEs), 33 pre-submissions, and has completed or is conducting 8 clinical studies. Honored with two Small Business Administration (SBA) Tibbetts Awards for SBIR commercialization excellence (2014 & 2020), Actuated operates out of a state-of-the-art 20,000 sq. ft. facility in central Pennsylvania, certified ISO 13485 and a Woman-Owned Small Business (WOSB), reflecting its steadfast commitment to quality and innovation. actuatedmedical.com
More on The PennZone
- Sara Abbas Receives "Eniochos" Charioteer Award at 2026 Who is Who International Awards
- Detained at 95: South Korea's Prosecution of a Religious Leader Draws International Alarm
- CCHR: DOJ Takedown Exposes Over $220 Million Defrauded in Behavioral Mental Health Fraud Schemes
- Exeter Smiles Encourages Reading Families to Start Teen Braces This Summer
- ARC Technologies Announces Corporate Asset Sale of buildings, inventory and IP patents
###
For media inquiries, please contact Maureen L. Mulvihill, Ph.D. by phone at 814-355-0003 or email at info@actuatedmedical.com.
Additional information can be found by visiting:
ActuatedMedical.com
GripTract.com
ActuatedNeuroscience.com
TubeClear.com
Source: Actuated Medical, Inc.
Filed Under: Technology
0 Comments
Latest on The PennZone
- RAS AP Consulting Expands AP Governance & Automation Practice and Named Finalist for Heidelberg Materials SAP Vendor & Customer Data Project
- New Children's Book Teaches Kids the Lesson Its Author Spent a Career Learning: Your Worth Doesn't Need Permission
- Proper Sky Named to the 2026 MSP 501
- 100+ Episodes In, Liftoff with Keith Newman Tells Founders to Stop Publishing More
- Vierra Communities Adds Operations of Two Skilled Nursing Facilities in the DC Metro Area
- Slotozilla Introduces a Centralized Resource for World Cup Bonus Offers
- Webinar Announcement: Built for Trust: Latitude's 0 to 1 Compliance Playbook for Modern Cross-Border Payments
- OneVizion Names AI Leader Matthew Kirk as Chief Operating Officer to Drive Governed AI Across Telecom and Electric Utilities
- Dentists launch independent platform to help practices choose the right technology
- Contracting Resources Group Recognized by The Daily Record as a 2026 In the Lead: Best Women-Owned Businesses Honoree
- Woodforest Acceptance Solutions and AlpacaBOSS Launch Partnership
- New "Lakeside Picnic Ride" Package in Japan's Lake Chuzenji region of Nikko: July 1- November 30, 2026
- Former MP Shri GV Harsha Kumar Meets AICC President Mallikarjun Kharge
- Two Attorneys at The Stanley Law Group Named to 2026 South Carolina Super Lawyers List
- IGH Naturals Announces Peer-Reviewed HuMOLYTE® Study Published in Frontiers in Nutrition
- LINC to Host CEO Breakfast Forum on July 22
- The Explorer Shaped Guitar Still a Symbol of Heavy Music with New Releases
- Allstream Energy Partners Expands AI-Optimized Website Development Division to Meet Growing Demand in GEO / AEO Services
- Nola Blue announces 'Jumpin' Rockin Rhythm,' the autobiography of Duke Robillard
- America's Workforce Solution Named an OpenAI SMB Channel Partner, Bringing Enterprise-Grade AI to Main Street
